Noncanonical Activation of Notch1 Protein by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Controls Melanoma Cell Proliferation

被引:27
|
作者
Ma, Jun [1 ]
Tang, Xiaoying [1 ]
Wong, Poki [1 ]
Jacobs, Barbara [2 ]
Borden, Ernest C. [2 ]
Bedogni, Barbara [1 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44106 USA
关键词
Cell Proliferation; Matrix Metalloproteinase (MMP); Melanoma; Notch Receptor; Protein-Protein Interactions; TUMOR-CELLS; DROSOPHILA; PROGRESSION; MIGRATION; CLEAVES; GROWTH; DIFFERENTIATION; MELANOCYTES; INHIBITION; EXPRESSION;
D O I
10.1074/jbc.M113.516039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Notch1 is highly activated in melanoma where it plays protumorigenic functions, yet no Notch1-activating mutations have been identified in melanoma. Results: MT1-MMP operates as a novel protease that promotes Notch1 activation in melanoma cells. Conclusion: An MT1-MMP/Notch1 signaling pathway supports melanoma cell growth. Significance: Notch1 emerges as a new MT1-MMP substrate that plays important biological roles in melanoma. Notch1 is an evolutionarily conserved signaling molecule required for stem cell maintenance that is inappropriately reactivated in several cancers. We have previously shown that melanomas reactivate Notch1 and require its function for growth and survival. However, no Notch1-activating mutations have been observed in melanoma, suggesting the involvement of other activating mechanisms. Notch1 activation requires two cleavage steps: first by a protease and then by -secretase, which releases the active intracellular domain (Notch1(NIC)). Interestingly, although ADAM10 and -17 are generally accepted as the proteases responsible of Notch1 cleavage, here we show that MT1-MMP, a membrane-tethered matrix metalloproteinase involved in the pathogenesis of a number of tumors, is a novel protease required for the cleavage of Notch1 in melanoma cells. We find that active Notch1 and MT1-MMP expression correlate significantly in over 70% of melanoma tumors and 80% of melanoma cell lines, whereas such correlation does not exist between Notch1(NIC) and ADAM10 or -17. Modulation of MT1-MMP expression in melanoma cells affects Notch1 cleavage, whereas MT1-MMP expression in ADAM10/17 double knock-out fibroblasts restores the processing of Notch1, indicating that MT1-MMP is sufficient to promote Notch1 activation independently of the canonical proteases. Importantly, we find that MT1-MMP interacts with Notch1 at the cell membrane, supporting a potential direct cleavage mechanism of MT1-MMP on Notch1, and that MT1-MMP-dependent activation of Notch1 sustains melanoma cell growth. Together, the data highlight a novel mechanism of activation of Notch1 in melanoma cells and identify Notch1 as a new MT1-MMP substrate that plays important biological roles in melanoma.
引用
收藏
页码:8442 / 8449
页数:8
相关论文
共 50 条
  • [21] Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer
    Al-Raawi, Diaa
    Abu-El-Zahab, Helal
    El-Shinawi, Mohamed
    Mohamed, Mona Mostafa
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2011, 4 (04): : 265 - 275
  • [22] Expression of membrane-type matrix metalloproteinase-1 (MT1-MMP) correlates with the metastatic behaviour of melanoma cells.
    Kurschat, P
    Nischt, R
    Rockel, D
    Steurer, P
    Klein, EC
    Mauch, C
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 416 - 416
  • [23] The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP)
    Remacle, AG
    Rozanov, DV
    Baciu, PC
    Chekanov, AV
    Golubkov, VS
    Strongin, AY
    JOURNAL OF CELL SCIENCE, 2005, 118 (21) : 4975 - 4984
  • [24] Membrane-Type 1 Matrix Metalloproteinase (MT1-MMP): A predictive biomarker of chemotherapy response in osteosarcoma
    Biswas, Swethajit
    Rankin, Kenneth
    Long, Anna
    Nisar, Sohail
    Gerrand, Craig
    Dildey, Petra
    Lunec, John
    CANCER RESEARCH, 2012, 72
  • [25] Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization
    Sounni, NE
    Baramova, EN
    Munaut, C
    Maquoi, E
    Frankenne, F
    Foidart, JM
    Noël, A
    INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (01) : 23 - 28
  • [26] Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP)
    Cuffaro, Doretta
    Nuti, Elisa
    Gifford, Valentina
    Ito, Noriko
    Camodeca, Caterina
    Tuccinardi, Tiziano
    Nencetti, Susanna
    Orlandini, Elisabetta
    Itoh, Yoshifumi
    Rossello, Armando
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (01) : 196 - 207
  • [27] (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis
    Yamakawa, S
    Asai, T
    Uchida, T
    Matsukawa, M
    Akizawa, T
    Oku, N
    CANCER LETTERS, 2004, 210 (01) : 47 - 55
  • [28] Structure and promoter characterization of the human membrane-type-1 matrix metalloproteinase (MT1-MMP) gene
    Lohi, J
    Lehti, K
    Valtanen, H
    Parks, WC
    Keski-Oja, J
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 175A - 175A
  • [29] In vitro efficacy of a sterically stabilized immunoliposomes targeted to membrane type 1 matrix metalloproteinase (MT1-MMP)
    Atobe, Kazutaka
    Ishida, Tatsuhiro
    Ishida, Emi
    Hashimoto, Kouichi
    Kobayashi, Hideo
    Yasuda, Jyunko
    Aoki, Takanori
    Obata, Ken-ichi
    Kikuchi, Hiroshi
    Akita, Hidetaka
    Asai, Tomohiro
    Harashima, Hideyoshi
    Oku, Naoto
    Kiwada, Hiroshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (05) : 972 - 978
  • [30] Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in normal and keratoconus corneas
    Collier, SA
    Madigan, MC
    Penfold, PT
    CURRENT EYE RESEARCH, 2000, 21 (02) : 662 - 668